Alongside with the established senescence markers like CDKN1A and LMNB1, our transcriptome analysis identified a distinctive expression pattern, comprising genes upregulated across all cell lines exclusively during TIS, which may serve as a specific TIS signature in breast cancer. This evidence concerns the gene CDKN1A and breast cancer.